Julia Dai is a Dermatology physician. OpenAlex indexes 48 publications with 579 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5758 S Maryland Ave Fl 3
Chicago, IL 60637
Telephone
888-824-0200Registry record last updated 11 Jul 2018.
Clinical trials
- Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
Sponsor: M.D. Anderson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20243 payments
- Adaptive Biotechnologies CorporationProgram year20233 payments
- Ortho Dermatologics, a division of Bausch Health US, LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
32.4%Retinoid16.9%Bexarotene100%Part D≥15 patientsNucleoside Metabolic Inhibitor5.9%Fluorouracil100%Part D≥27 patients+ 2 more classes in this area
Dermatology
23.8%Corticosteroid20.9%Triamcinolone Acetonide100%Part D≥68 patientsInterleukin-4 Receptor alpha Antagonist2.9%Dupixent Pen100%Part D<11 patientsSensory organs
12.5%Corticosteroid12.5%Clobetasol Propionate71%Hydrocortisone29%Part D≥33 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Rare Case of Cutaneous Crystal‐Storing Histiocytosis With Kappa Light Chain Restriction and Unusual <scp>BCL6</scp> Expression
Journal of Cutaneous Pathology
2026 - Long-term outcomes in juvenile-onset mycosis fungoides
Journal of the American Academy of Dermatology
2026 - Subcutaneous Panniculitis-Like T-Cell Lymphoma With Increased γδ T Cells: A Potential Diagnostic Pitfall
American Journal of Dermatopathology
2025 - Second primary malignancies in mycosis fungoides/Sézary syndrome patients
European Journal of Cancer
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”